It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Cynomolgus macaque (Macaca fascicularis) and common marmoset (Callithrix jacchus) have been widely used in human biomedical research. Long-standing primate genome assemblies used the human genome as a reference for ordering and orienting the assembled fragments into chromosomes. Here we performed de novo genome assembly of these two species without any human genome-based bias observed in the genome assemblies released earlier. We assembled PacBio long reads, and the resultant contigs were scaffolded with Hi-C data, which were further refined based on Hi-C contact maps and alternate de novo assemblies. The assemblies achieved scaffold N50 lengths of 149 Mb and 137 Mb for cynomolgus macaque and common marmoset, respectively. The high fidelity of our assembly is also ascertained by BAC-end concordance in common marmoset. Our assembly of cynomolgus macaque outperformed all the available assemblies of this species in terms of contiguity. The chromosome-scale genome assemblies produced in this study are valuable resources for non-human primate models and provide an important baseline in human biomedical research.
Measurement(s) | sequence_assembly • genome • DNA |
Technology Type(s) | sequence assembly process • DNA sequencing |
Sample Characteristic - Organism | Macaca fascicularis • Callithrix jacchus |
Machine-accessible metadata file describing the reported data:
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details





1 Keio University, Department of Biosciences and Informatics, Yokohama, Japan (GRID:grid.26091.3c) (ISNI:0000 0004 1936 9959)
2 RIKEN Center for Biosystems Dynamics Research, Laboratory for Phyloinformatics, Hyogo, Japan (GRID:grid.508743.d)
3 RIKEN Center for Integrative Medical Science Preventive Medicine and Applied Genomics Unit, Yokohama, Japan (GRID:grid.509459.4) (ISNI:0000 0004 0472 0267); Tokyo Metropolitan Institute of Medical Science, Research Center for Genome & Medical Sciences, Tokyo, Japan (GRID:grid.272456.0); Kyoto University, Institute for the Advanced Study of Human Biology, Kyoto, Japan (GRID:grid.258799.8) (ISNI:0000 0004 0372 2033)
4 RIKEN Center for Integrative Medical Science Preventive Medicine and Applied Genomics Unit, Yokohama, Japan (GRID:grid.509459.4) (ISNI:0000 0004 0472 0267); RIKEN Center for Integrative Medical Sciences RIKEN-IFOM Joint Laboratory for Cancer Genomics, Yokohama, Japan (GRID:grid.509459.4) (ISNI:0000 0004 0472 0267)
5 RIKEN Center for Integrative Medical Sciences RIKEN-IFOM Joint Laboratory for Cancer Genomics, Yokohama, Japan (GRID:grid.509459.4) (ISNI:0000 0004 0472 0267); RIKEN Preventive Medicine and Diagnosis Innovation Program, Yokohama, Japan (GRID:grid.7597.c) (ISNI:0000000094465255); Kyoto University, Institute for the Advanced Study of Human Biology, Kyoto, Japan (GRID:grid.258799.8) (ISNI:0000 0004 0372 2033); Kyoto University, Department of Medical Systems Genomics, Graduate School of Medicine, Kyoto, Japan (GRID:grid.258799.8) (ISNI:0000 0004 0372 2033); IFOM-the FIRC Institute of Molecular Oncology, Milan, Italy (GRID:grid.7678.e) (ISNI:0000 0004 1757 7797)
6 RIKEN Center for Integrative Medical Sciences Laboratory for Comprehensive Genomic Analysis, Yokohama, Japan (GRID:grid.509459.4) (ISNI:0000 0004 0472 0267)
7 Shiga University of Medical Science, Department of Stem Cells and Human Disease Models, Research Center for Animal Life Science, Shiga, Japan (GRID:grid.410827.8) (ISNI:0000 0000 9747 6806); Kyoto University, Institute for the Advanced Study of Human Biology (WPI-ASHBi), Kyoto, Japan (GRID:grid.258799.8) (ISNI:0000 0004 0372 2033)
8 Shiga University of Medical Science, Department of Stem Cells and Human Disease Models, Research Center for Animal Life Science, Shiga, Japan (GRID:grid.410827.8) (ISNI:0000 0000 9747 6806)
9 RIKEN Preventive Medicine and Diagnosis Innovation Program, Yokohama, Japan (GRID:grid.7597.c) (ISNI:0000000094465255)
10 Central Institute for Experimental Animals, Central Institute for Experimental Animals, Department of Marmoset Biology and Medicine, Kawasaki, Japan (GRID:grid.452212.2) (ISNI:0000 0004 0376 978X)
11 RIKEN Center for Integrative Medical Science Preventive Medicine and Applied Genomics Unit, Yokohama, Japan (GRID:grid.509459.4) (ISNI:0000 0004 0472 0267); Tokyo Metropolitan Institute of Medical Science, Research Center for Genome & Medical Sciences, Tokyo, Japan (GRID:grid.272456.0); RIKEN Preventive Medicine and Diagnosis Innovation Program, Yokohama, Japan (GRID:grid.7597.c) (ISNI:0000000094465255)